黑料网

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 790

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Dhiren R Thakker

Dhiren R Thakker

Dhiren R Thakker
Professor
Eshelman School of Pharmacy
The University of North Carolina
USA

The University of North Carolina

Biography

Dr. Thakker is the Howard Q Ferguson Distinguished Professor, Associate Dean for Entrepreneurial Development and Global Engagement, and Director, Bill and Karen Campbell Faculty Mentoring Program at the UNC Eshelman School of Pharmacy, the University of North Carolina at Chapel Hill. From 1998 to 2008, he served as the Associate Dean for Research and Graduate Education.

Prior to joining UNC in 1996, Dr. Thakker spent (i) eight years at Glaxo Inc. where he was Director of Drug Metabolism Department, (ii) four years at the Center for Biologics, FDA, and (iii) eight years at the National Institutes of Health. He obtained Batchelor of Pharmacy from Bombay University, India, M.S. in Pharmaceutical Chemistry from Columbia University, New York, and Ph.D. in Biochemistry from the University of Kansas at Lawrence.

Dr. Thakker has published over 160 peer-reviewed papers, reviews and book chapters and co-edited two books. His current research interests are (i) mechanisms of drug transport across intestine, (ii) novel intestinal absorption mechanism and pharmacology of metformin as anti-diabetic and anti-cancer drug, and (iii) optimizing pediatric dosing by study of drug metabolism and transport in children and adults. In the past he has worked on mechanismbased design of intestinal absorption enhancers, stereo-selectivity of cytochrome P-450 enzymes, chemical carcinogenesis by metabolic activation of polycyclic aromatic hydrocarbon, and catechol O-methyl transferase enzymology.

Research Interest

Mechanisms of drug transport; structure-transport relationships; prodrug strategies for tumor-targeting; metabolism of drugs and xenobiotics; delivery and disposition of macromolecules

Certificate

Certificate
International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top